MA56179A - Traitement de synucléinopathies - Google Patents
Traitement de synucléinopathiesInfo
- Publication number
- MA56179A MA56179A MA056179A MA56179A MA56179A MA 56179 A MA56179 A MA 56179A MA 056179 A MA056179 A MA 056179A MA 56179 A MA56179 A MA 56179A MA 56179 A MA56179 A MA 56179A
- Authority
- MA
- Morocco
- Prior art keywords
- synucleinopathies
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921023164 | 2019-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56179A true MA56179A (fr) | 2022-04-20 |
Family
ID=71094647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056179A MA56179A (fr) | 2019-06-11 | 2020-06-09 | Traitement de synucléinopathies |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220257582A1 (fr) |
| EP (1) | EP3982964A1 (fr) |
| JP (1) | JP2022536331A (fr) |
| KR (1) | KR20220024463A (fr) |
| CN (1) | CN114040763A (fr) |
| AU (1) | AU2020292703A1 (fr) |
| BR (1) | BR112021024835A2 (fr) |
| CA (1) | CA3142899A1 (fr) |
| CL (1) | CL2021003303A1 (fr) |
| EA (1) | EA202193211A1 (fr) |
| IL (1) | IL288797A (fr) |
| MA (1) | MA56179A (fr) |
| MX (1) | MX2021015390A (fr) |
| WO (1) | WO2020250133A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023214314A1 (fr) | 2022-05-02 | 2023-11-09 | Sun Pharma Advanced Research Company Limited | Vodobatinib pour freiner la progression de la maladie de parkinson |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910586B2 (en) | 2002-01-04 | 2011-03-22 | The Rockefeller University | Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders |
| WO2003080061A1 (fr) | 2002-03-21 | 2003-10-02 | Dana-Farber Cancer Institute, Inc. | Inhibition de reponses de mort cellulaire induite par stress oxydatif |
| TWI343806B (en) | 2003-07-01 | 2011-06-21 | Nat Health Research Institutes | Methods of inhibiting neurodegenerative disease |
| US8618063B2 (en) | 2008-04-09 | 2013-12-31 | The Board Of Trustees Of The University Of Illinois | Method for treating a synucleinopathy |
| US9024021B2 (en) | 2011-01-21 | 2015-05-05 | Sun Pharma Advanced Research Company Ltd. | Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
| WO2012139027A1 (fr) | 2011-04-07 | 2012-10-11 | Ariad Pharmaceuticals, Inc. | Procédés et compositions pour le traitement de maladies neurodégénératives |
| ES2943113T3 (es) * | 2012-05-02 | 2023-06-09 | Univ Georgetown | Tratamiento de la esclerosis lateral amiotrófica con inhibidores de las tirosina cinasas |
| MY193754A (en) | 2016-06-02 | 2022-10-27 | Sun Pharma Advanced Res Co Ltd | Treatment for parkinson's disease |
-
2020
- 2020-06-09 EA EA202193211A patent/EA202193211A1/ru unknown
- 2020-06-09 KR KR1020227000774A patent/KR20220024463A/ko unknown
- 2020-06-09 AU AU2020292703A patent/AU2020292703A1/en active Pending
- 2020-06-09 EP EP20733026.7A patent/EP3982964A1/fr active Pending
- 2020-06-09 CA CA3142899A patent/CA3142899A1/fr active Pending
- 2020-06-09 US US17/618,230 patent/US20220257582A1/en active Pending
- 2020-06-09 CN CN202080042470.8A patent/CN114040763A/zh active Pending
- 2020-06-09 MA MA056179A patent/MA56179A/fr unknown
- 2020-06-09 BR BR112021024835A patent/BR112021024835A2/pt unknown
- 2020-06-09 WO PCT/IB2020/055425 patent/WO2020250133A1/fr unknown
- 2020-06-09 MX MX2021015390A patent/MX2021015390A/es unknown
- 2020-06-09 JP JP2021573203A patent/JP2022536331A/ja active Pending
-
2021
- 2021-12-08 IL IL288797A patent/IL288797A/en unknown
- 2021-12-10 CL CL2021003303A patent/CL2021003303A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3142899A1 (fr) | 2020-12-17 |
| EA202193211A1 (ru) | 2022-03-30 |
| IL288797A (en) | 2022-02-01 |
| KR20220024463A (ko) | 2022-03-03 |
| CN114040763A (zh) | 2022-02-11 |
| CL2021003303A1 (es) | 2022-08-19 |
| MX2021015390A (es) | 2022-01-24 |
| JP2022536331A (ja) | 2022-08-15 |
| WO2020250133A1 (fr) | 2020-12-17 |
| EP3982964A1 (fr) | 2022-04-20 |
| AU2020292703A1 (en) | 2022-01-27 |
| US20220257582A1 (en) | 2022-08-18 |
| BR112021024835A2 (pt) | 2022-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46954A (fr) | Méthodes de traitement d'états inflammatoires | |
| MA48730A (fr) | Compositions et méthodes de traitement de synucléinopathies | |
| MA47719A (fr) | Esketamine pour le traitement de la dépression | |
| IT201700081018A1 (it) | Trattamento di segnali elettrofisiologici | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| MA52219A (fr) | Traitement de l'hidradénite suppurée à l'aide d'inhibiteurs de jak | |
| MA47820A (fr) | Traitement de la glycogénose de type iii | |
| MA51738A (fr) | Composés pour le traitement de la douleur | |
| MA53553A (fr) | Traitement post-chirurgical de la douleur | |
| DK3548061T3 (da) | Behandling af neurologiske sygdomme | |
| MA52218A (fr) | Traitement de cancers associés à trk | |
| MA42999A (fr) | Polythérapie pour le traitement de malignités | |
| MA51525A (fr) | Traitement de minéraux | |
| MA55218A (fr) | Eskétamine pour le traitement de la dépression | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| MA53236A (fr) | Traitement des malignités des lymphocytes b | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases | |
| MA56179A (fr) | Traitement de synucléinopathies | |
| MA56033A (fr) | Méthodes de traitement de la sclérodermie généralisée | |
| MA41782A (fr) | Traitement de patients atteints de diabète de type 2 | |
| GB201907305D0 (en) | Treatment of conditions | |
| ES2982000T3 (es) | Tratamiento y prevención de la preeclampsia | |
| MA48625A (fr) | Composés et méthodes de traitement de la douleur viscérale | |
| IL290880A (en) | Treatment of symptoms induced by the menstrual cycle | |
| EP4003283C0 (fr) | Traitement d'affections cutanées inflammatoires |